Rion Co., Ltd. (RIOXF)
OTCMKTS · Delayed Price · Currency is USD
14.63
+0.03 (0.21%)
At close: Jun 16, 2025
Rion Co., Ltd. Revenue
Rion Co., Ltd. had revenue of 6.93B JPY in the quarter ending December 31, 2025, a decrease of -6.94%. This brings the company's revenue in the last twelve months to 27.94B, up 0.84% year-over-year. In the fiscal year ending March 31, 2025, Rion Co., Ltd. had annual revenue of 27.88B with 8.36% growth.
Revenue (ttm)
27.94B JPY
Revenue Growth
+0.84%
P/S Ratio
1.31
Revenue / Employee
27.69M JPY
Employees
1,009
Market Cap
232.60M USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 27.88B | 2.15B | 8.36% |
| Mar 31, 2024 | 25.73B | 1.86B | 7.78% |
| Mar 31, 2023 | 23.87B | 1.23B | 5.45% |
| Mar 31, 2022 | 22.64B | 2.17B | 10.60% |
| Mar 31, 2021 | 20.47B | -999.00M | -4.65% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zomedica | 29.45M |
| OpGen | 9.00M |
| Tian'an Technology Group | 2.12M |
| PetVivo Holdings | 1.41M |
| Positron | 486.45K |
| Guided Therapeutics | 178.00K |
| CS Diagnostics | 98.73K |
| Vivos | 48.62K |